/CDIO
CDIO Stock - Cardio Diagnostics Holdings, Inc.
Healthcare|BiotechnologyNASDAQ
$3.23+14.54%
+$0.41 (+14.54%) • Dec 19
36
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.5
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $3.55
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CDIO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.20 – $3.26
TARGET (TP)$3.71
STOP LOSS$2.97
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.87
52W High$31.80
52W Low$2.42
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $34,890 | $17,065 | $950 | $901 | N/A |
| Gross Profit | $34,890 | $17,065 | $950 | $901 | N/A |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | N/A |
| Operating Income | $-8,365,877 | $-7,242,459 | $-4,548,451 | $-620,448 | $-609,164 |
| Net Income | $-8,383,453 | $-8,376,834 | $-4,660,985 | $-620,448 | $-605,164 |
| Net Margin | -24028.2% | -49087.8% | -490630.0% | -68862.2% | N/A |
| EPS | $-9.30 | $-19.80 | $-45.30 | $-1.96 | $-0.06 |
Company Overview
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CDIOBeat Rate
77%
Last 13 quarters
Avg Surprise
+16.2%
EPS vs Estimate
Beats / Misses
10/3
Last 12 quarters
Latest EPS
$-0.98
Q4 2025
EPS Surprise History
Q1 24
+48.0%
$-0.07vs$-0.13
Q2 24
-53.8%
$-0.20vs$-0.13
Q3 24
+45.5%
$-0.06vs$-0.11
Q4 24
+60.0%
$-0.06vs$-0.15
Q1 25
+83.3%
$-0.01vs$-0.06
Q2 25
+46.1%
$-0.97vs$-1.80
Q3 25
+46.1%
$-0.97vs$-1.80
Q4 25
+45.6%
$-0.98vs$-1.80
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q1 2026 | Mar 18, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | $-1.80 | $-0.98 | +45.6% | ✓ BEAT |
Q3 2025 | Aug 14, 2025 | $-1.80 | $-0.97 | +46.1% | ✓ BEAT |
Q2 2025 | May 15, 2025 | $-1.80 | $-0.97 | +46.1% | ✓ BEAT |
Q1 2025 | Mar 20, 2025 | $-0.06 | $-0.01 | +83.3% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $-0.15 | $-0.06 | +60.0% | ✓ BEAT |
Q3 2024 | Aug 12, 2024 | $-0.11 | $-0.06 | +45.5% | ✓ BEAT |
Q2 2024 | May 15, 2024 | $-0.13 | $-0.20 | -53.8% | ✗ MISS |
Q1 2024 | Mar 25, 2024 | $-0.13 | $-0.07 | +48.0% | ✓ BEAT |
Q4 2023 | Nov 13, 2023 | $-0.28 | $-0.16 | +42.9% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.18 | $-0.39 | -116.7% | ✗ MISS |
Q2 2023 | May 26, 2023 | $-0.18 | $-0.11 | +38.9% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $-0.09 | $-0.25 | -177.7% | ✗ MISS |
Q4 2022 | Nov 7, 2022 | $-0.66 | $0.02 | +103.0% | ✓ BEAT |
Q3 2022 | Aug 10, 2022 | — | $-0.09 | — | — |
Q2 2022 | May 12, 2022 | — | $-0.03 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.02 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.13 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Latest News
Cardio Diagnostics Announces Centers for Medicare and Medicaid Services Issued Final Gapfill Payment Rate Of $854 For Epi+Gen CHD And PrecisionCHD Tests
📈 PositiveBenzinga•Dec 3, 2025, 01:37 PM
Cardio Diagnostics' PrecisionCHD Test To Detect Hidden Forms Of Heart Disease INOCA And MINOCA, To Be Presented At AHA Sessions
📈 PositiveBenzinga•Nov 5, 2025, 01:37 PM
Cardio Diagnostics Enters Partnerships With 15 New U.S. Provider Organizations, Expanding Adoption Of Its AI-driven Blood Tests, Epi+Gen CHD And PrecisionCHD Which Aim To Improve Prevention, Detection, And Management Of Coronary Heart Disease Across Diverse Clinical Settings
📈 PositiveBenzinga•Oct 21, 2025, 12:38 PM
Cardio Diagnostics drops on 1-for-30 reverse stock split
📉 NegativeSeeking Alpha•May 8, 2025, 12:48 PM
Frequently Asked Questions about CDIO
What is CDIO's current stock price?
Cardio Diagnostics Holdings, Inc. (CDIO) is currently trading at $3.23 per share. The stock has moved +14.54% today.
What is the analyst price target for CDIO?
No analyst price targets are currently available for this stock.
What sector is Cardio Diagnostics Holdings, Inc. in?
Cardio Diagnostics Holdings, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is CDIO's market cap?
Cardio Diagnostics Holdings, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does CDIO pay dividends?
No, Cardio Diagnostics Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADIL
Adial Pharmaceuticals, Inc.
$0.24
Mkt Cap: $0.0B
ADXN
Addex Therapeutics Ltd
$7.83
Mkt Cap: $0.0B
BCDA
BioCardia, Inc.
$1.27
Mkt Cap: $0.0B
BCLI
Brainstorm Cell Therapeutics Inc.
$0.56
Mkt Cap: $0.0B
CELZ
Creative Medical Technology Holdings, Inc.
$2.11
Mkt Cap: $0.0B
IBO
Impact BioMedical Inc.
$0.65
Mkt Cap: $0.0B
MTNB
Matinas BioPharma Holdings, Inc.
$0.73
Mkt Cap: $0.0B
NRSN
NeuroSense Therapeutics Ltd.
$0.81
Mkt Cap: $0.0B
RADX
Radiopharm Theranostics Limited
$5.19
Mkt Cap: $0.0B
TCRT
Alaunos Therapeutics, Inc.
$3.56
Mkt Cap: $0.0B
Explore stocks similar to CDIO for comparison